These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25299917)

  • 21. First inhalable insulin approved.
    Katsnelson A
    Nat Biotechnol; 2006 Apr; 24(4):369-70. PubMed ID: 16601705
    [No Abstract]   [Full Text] [Related]  

  • 22. Biopharmaceutical benchmarks 2006.
    Walsh G
    Nat Biotechnol; 2006 Jul; 24(7):769-76. PubMed ID: 16841057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Michigan's next wave of biopharmaceutical entrepreneurship.
    Kerppola R; van de Walle M; Surine S
    Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575
    [No Abstract]   [Full Text] [Related]  

  • 24. Biotechs hold their own in shifting industry.
    Mitchell P
    Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
    [No Abstract]   [Full Text] [Related]  

  • 25. Evolution and future of biopharmaceuticals.
    Health Aff (Millwood); 2006; 25(5):1270. PubMed ID: 16966722
    [No Abstract]   [Full Text] [Related]  

  • 26. A rollercoaster ride.
    Jacobs T
    Nat Biotechnol; 2006 Mar; 24(3):284. PubMed ID: 16525390
    [No Abstract]   [Full Text] [Related]  

  • 27. The challenges of product- and process-related impurities to an evolving biopharmaceutical industry.
    Bracewell DG; Smales CM
    Bioanalysis; 2013 Jan; 5(2):123-6. PubMed ID: 23330553
    [No Abstract]   [Full Text] [Related]  

  • 28. Biopharmaceutical benchmarks.
    Walsh G
    Nat Biotechnol; 2000 Aug; 18(8):831-3. PubMed ID: 10932150
    [No Abstract]   [Full Text] [Related]  

  • 29. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomanufacturing, from bust to boom...to bubble?
    Thiel KA
    Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
    [No Abstract]   [Full Text] [Related]  

  • 31. Private company profiles.
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE23-8. PubMed ID: 12874973
    [No Abstract]   [Full Text] [Related]  

  • 32. Setting the stage for biosimilar monoclonal antibodies.
    Schneider CK; Vleminckx C; Gravanis I; Ehmann F; Trouvin JH; Weise M; Thirstrup S
    Nat Biotechnol; 2012 Dec; 30(12):1179-85. PubMed ID: 23222783
    [No Abstract]   [Full Text] [Related]  

  • 33. The US Biosimilar Market: Stunted Growth and Possible Reforms.
    Sarpatwari A; Barenie R; Curfman G; Darrow JJ; Kesselheim AS
    Clin Pharmacol Ther; 2019 Jan; 105(1):92-100. PubMed ID: 30415479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trials and error.
    Jacobs T
    Nat Biotechnol; 2005 Dec; 23(12):1481. PubMed ID: 16333284
    [No Abstract]   [Full Text] [Related]  

  • 35. BIO and biogenerics.
    Feldbaum CB
    Nat Biotechnol; 2005 Jan; 23(1):17; discussion 17. PubMed ID: 15637607
    [No Abstract]   [Full Text] [Related]  

  • 36. Overdue process.
    Nat Biotechnol; 2004 Nov; 22(11):1329. PubMed ID: 15529137
    [No Abstract]   [Full Text] [Related]  

  • 37. Going it alone.
    Senior M
    Nat Biotechnol; 2014 May; 32(5):411-4. PubMed ID: 24811507
    [No Abstract]   [Full Text] [Related]  

  • 38. The biotechnology sector's craving for commercial expertise is fuelling a cultural exchange with drug industry.
    Smaglik P; Frantz S
    Nature; 2003 Apr; 422(6931):542-3. PubMed ID: 12673255
    [No Abstract]   [Full Text] [Related]  

  • 39. How Indian biotech is driving innovation.
    Nogrady B
    Nature; 2018 Dec; 564(7735):S53-S55. PubMed ID: 30542184
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal antibody: the corner stone of modern biotherapeutics.
    Xia ZN; Cai XT; Cao P
    Yao Xue Xue Bao; 2012 Oct; 47(10):1275-80. PubMed ID: 23289138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.